| Date Filed | Type | Description |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
4
| Baylor-Henry Minnie (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
4
| VEITINGER KLAUS R DR (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
4
| Abraham William Tober (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
4
| Hudson Frederick M. (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
4
| Bonstein Sara (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
4
| Khattar Jack A. (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
4
| SCHAEFFER LEONARD D (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/07/2023 |
8-K
| Other Events Interactive Data |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/22/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/22/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/22/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/22/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
SC 13G
| MILLENNIUM MANAGEMENT LLC reports a 5.1% stake in SCPHARMACEUTICALS INC. |
| 03/10/2023 |
8-K
| Other Events Interactive Data |
| 02/27/2023 |
SC 13G
| Cowen Financial Products LLC reports a 7.1% stake in scPHarmaceuticals Inc. |
| 02/14/2023 |
SC 13G/A
| 5AM Ventures IV, L.P. reports a 8% stake in scPharmaceuticals Inc. |
| 02/14/2023 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 6.3% stake in SCPHARMACEUTICALS INC. |
| 01/23/2023 |
4
| Tucker John H (President and CEO) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 66,665 shares
@ $6.14, valued at
$409.3k
Granted 100,000 options to buy
@ $6.14, valued at
$614k
|
|
| 01/23/2023 |
4
| Nokes Rachael (See Remarks) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Paid exercise price by delivering 1,981 shares
@ $10.09, valued at
$20k
Paid exercise price by delivering 1,976 shares
@ $7.27, valued at
$14.4k
Granted 11,700 shares
@ $6.14, valued at
$71.8k
Granted 17,550 options to buy
@ $6.14, valued at
$107.8k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
8-K
| Quarterly results |
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/25/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/23/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 11/23/2022 |
8-K
| Quarterly results |
|